Moderna (MRNA) Treasury Shares (2017)
Moderna's (MRNA) quarterly Treasury Shares came in at $448.7 million in Q4 2017.
Powered by 
Analysis
Moderna (MRNA) Treasury Shares (2017) Analysis & Trends
Moderna (MRNA) has reported Treasury Shares for 1 consecutive years, with $448.7 million the latest figure, recorded in Q4 2017.
- On a quarterly basis, Treasury Shares changed N/A year-over-year to $448.7 million in Q4 2017; TTM through Dec 2017 was $448.7 million, a N/A change from a year earlier, with the FY2017 full-year figure at $448.7 million, changed 0.0% from the prior year.
- Treasury Shares was $448.7 million for Q4 2017 at Moderna.
- Over five years, Treasury Shares peaked at $448.7 million in Q4 2017 and troughed at $448.7 million in Q4 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 36.40 Mn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | -23.80 Mn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | - |
| 10 | BioNTech SE | 26.24 Bn | 12.58 Bn | 10.00 Mn | -9.07 Mn |